Kevin Ingham, VP Manufacturing Operations and Site Head J.POD Redmond, presented at BioManufacturing World Summit in November 2024. 
 

Topics discussed:

• Just – Evotec Biologics is transforming the biomanufacturing industry with a fully integrated, continuous manufacturing platform
• Our proprietary continuous biomanufacturing platform enables us to reduce costs while maintaining top-tier quality from the clinical to the commercial stage
• Our modular state-of-the art J.POD® facilities in Redmond, WA and Toulouse, France are fully flexible in response to demand fluctuations
• We are partnering with leading biotech, pharma, biosimilar players, and governments to drive these advancements as the fastest growing CTDMO